| Session 1: Biosafety in the Field |
| Stewart Cole |
Genomics and the origin of leprosy
(PDF, 6.05 MB) |
| Erik Paus |
Management and transport of intoxicated (chemicals and /or biological) patients: are we prepared? (PDF, 7.84 MB) |
| Tamar Kohn |
Virus inactivation in sunlit surface water (PDF, 1.10 MB) |
| Michael Winzeler |
Biosafety and security measures in field experiment with transgenic wheat in Switzerland (PDF, 2.83 MB) |
 |
| Session 2: Biosafety in the Lab – Diagnostics and Research |
| Susan Caskey |
Biosafety Risk Assessment and Models: Advantages and Limits to Modelling Biosafety Using a Quantitative Process (PDF, 0.56 MB) |
| Matthias Niedrig |
Diagnostic of imported viral pathogens in Europe (PDF, 11.50 MB) |
| Jürgen Mertsching |
Working with M. Tuberculosis: Risk assessment in patient care, diagnosis and research (PDF, 2.84 MB) |
| Eveline Kampert |
Biosafety versus biosecurity: synergy and potential conflicts (PDF, 0.48 MB) |
| Jens Peter Teifke |
Implementation of the CWA 15793 to develop a biorisk management system at the Friedrich-Loeffler-Institut (FLI) – First experiences (PDF, 5.16 MB) |
|
| Session 3: Biosafety in the Lab – Technical Installations |
| Brian Rappert |
Strengthening the Prohibition through Education: Experiences, Resources, and Models (PDF, 1.86 MB) |
| Andreas Lüthi |
Planning and Design of a High Containment Laboratory (PDF, 13.14 MB) |
| Axel Mahler |
Modern Demands in Biosafety Air Filtration Units (PDF, 3.63 MB) |
| Volker Luh |
Thermal Waste Water Sterilisation, the Safe Way to Inactivate (PDF, 1.62 MB) |
Markus Spörri
Jörg Frank, |
VHP Fumigation and Ventilation Systems: A Possible Solution (PDF, 4.90 MB) |
| Joachim Frey |
Biosafety in the laboratory – biosafety from the laboratory (PDF, 0.93 MB) |
|
| Session 4: Basic and Applied Research |
| Stephan Kunz |
Novel therapeutic strategies against emerging human pathogenic arenaviruses (PDF, 4.10 MB) |
| Elena Ryabchikova |
Electron microscopic abilities for diagnostics of danger viral infections (PDF, 2.23 MB) |
| Hermann Meyer |
Laboratory diagnostics for orthopoxviruses (PDF, 1.49 MB) |
| Gerd Pluschke |
Use of synthetic antigens in the development of new diagnostic tools and vaccines (PDF, 1.25 mb) |
Marco Tamborrini
|
Use of synthetic antigens in the development of new vaccines and diagnostic tools (PDF, 0.55 MB) |
| Rahel Gäumann |
Molecular epidemiology of tick-borne encephalitis viruses in Switzerland (PDF, 1.77 MB) |
| Lukas Flatz |
T cell-dependence of Lassa fever pathogenesis (PDF, 1.09 MB) |
|
| Session 5: High-Containment Lab Spiez |
| Daniel Lavanchy |
High Containment Laboratories in the Context of Global Health Security (PDF, 1.72 MB) |
Martin Schütz
Marc Strasser |
High containment lab, Spiez: Initial vision and plans – future tasks and collaborations (PDF, 5.01 MB) |
| Peter Mani |
EIS, Laboratory Design and Design Review (PDF, 1.54 MB) |
| Daniel Kümin |
Biorisk Management at SPIEZ LABORATORY: Concept and Training (PDF, 1.35 MB) |
| Jim Welch |
The Need for Skills Training – An Outsiders View (PDF, 1.12 MB) |
| Sean Kaufman |
A True Training Experience: Lessons Learned in Behavioral-Biosafety Training (PDF, 1.70 MB) |
| Murray Cohen |
NBBTP: putative program partner (PDF, 1.00 MB) |
| |
|
